IQInvest
Sign in

NVDA

NVIDIA Corporation

NMS · Technology

$212.68

$4.20 (+2.01%)up 2.01%

25 August 2026 · delayed 15+ min

D

Quality score63.8 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

NVIDIA Corporation earns a D on excellent profit margins (>20%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and MACD bearish (negative histogram). Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 2.8% · $280.00 IQInvest estimate
Adjusted for Medium-term investors 2.8% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-NVDA-20260825engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$164.07

Lowest analyst target

$180.00

Today's price

$212.68

52-week high

$236.54

Mean analyst target

$304.73

Highest analyst target

$500.00

NVDA trades 67% of the way up its 52-week range, between $164.07 and $236.54. The mean analyst target of $304.73 is 43.3% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Strong ROE (>20%); High debt-to-equity ratio (>2.0) 100.023%

Profit margin

62.97%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

65.60%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

74.14%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

114.29%

Profit per unit of shareholder capital

very strongWhat this means

Profit generated per unit of shareholder capital.

Rare when sustained — check whether debt is flattering it, since borrowing shrinks the equity denominator.

Return on assets

52.73%

Profit per unit of assets

very strongWhat this means

Profit generated per unit of everything the company owns.

Usually an asset-light business — the value is in people and brands, not property.

Debt to equity

6.55

Borrowings against equity

conservativeWhat this means

Borrowings measured against shareholder capital.

Comfortably financed.

Current ratio

3.44

Short-term assets over short-term debts

very liquidWhat this means

Short-term assets against short-term obligations.

Plenty of cover, though idle cash earns little.

Quick ratio

2.14

As above, excluding inventory

comfortableWhat this means

Short-term assets excluding inventory, against short-term debts.

Liquid assets exceed short-term obligations.

Revenue growth

85.20%

Year on year

fast-growingWhat this means

Change in revenue against the same period last year.

Rapid growth, though the question is always how long it can hold.

Earnings growth

214.50%

Year on year

very strongWhat this means

Change in earnings against the same period last year.

Check whether it is repeatable or a one-off — a single asset sale can flatter this badly.

Revenue

$81.61B

Trailing twelve months

Free cash flow

$46.34B

Cash left after capital spending

Operating cash flow

$125.65B

Cash from the business itself

Payout ratio

0.61%

Dividends as a share of earnings

conservativeWhat this means

The share of earnings paid out as dividends.

Comfortably covered, with room to keep raising it.

Growth & momentumSevere max drawdown (-66.3%); High volatility 50.022%

Return, 1 month

7.95%

Return, 3 months

0.15%

Return, 6 months

8.88%

Return, year to date

12.75%

Return, 1 year

18.44%

Return, 3 years

353.70%

Sharpe ratio

1.10

Return earned per unit of risk

strongWhat this means

Return earned per unit of risk taken.

Above 1 the return has been generous relative to the swings involved.

Win rate

53.11%

Share of days that closed up

consistently positiveWhat this means

The share of trading days that closed higher.

More up days than most shares manage.

Average daily return

0.23%

Best day

24.37%

Worst day

-16.97%

ValuationAttractive PEG ratio (0.59); High P/B ratio (26.35) 45.018%

P/E ratio

32.57

Price against trailing earnings

highWhat this means

You pay 32.57 for every 1 unit of annual earnings.

Above about 25 the market is paying up for expected growth.

Forward P/E

16.31

Price against forecast earnings

moderateWhat this means

Price against next year's *forecast* earnings.

A conventional range.

PEG ratio

0.59

P/E adjusted for growth

cheap for the growthWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Under 1 is the classic Peter Lynch marker for growth you are not paying full price for.

Price to book

26.35

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

20.32

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

30.24

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

$5.00T

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

24,221,000,000

Shares the profit is split across

Dividend yield

0.48%

Annual dividend against price

modestWhat this means

Annual dividend as a percentage of the share price.

A small income component.

TechnicalRSI in healthy range (30-70); MACD bearish (negative histogram) 70.015%

RSI (14)

49.2

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

2.17

Momentum against its own trend

MACD histogram

-1.29

Positive is bullish

ADX

17.0

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$214.56

50-day average

$207.80

200-day average

$195.26

Price vs 50-day

2.35%

Price vs 200-day

8.92%

Bollinger upper

$234.06

Bollinger lower

$195.06

Average true range

6.40

Typical daily trading range

Stochastic %K

26.2

RiskHigh volatility risk; High beta (2.21) - more volatile than market 10.012%

Volatility, annualised

51.83%

How far it swings in a year

turbulentWhat this means

How far the price typically swings over a year.

Large swings in both directions — position size matters more than usual here.

Beta

2.21

Moves against the wider market

more volatile than the marketWhat this means

How much the price moves relative to the wider market.

Amplifies the index — bigger gains, bigger falls.

Maximum drawdown

-66.34%

Worst peak-to-trough fall

severeWhat this means

The worst peak-to-trough fall in the period measured.

A fall this deep needs roughly a doubling to recover.

Risk category

Very High

The engine's own banding

Analyst viewAnalyst consensus: Strong Buy; Significant upside potential (43.3%) 100.010%

Consensus

Strong Buy

What covering analysts rate it

Analysts covering

59

Mean price target

$304.73

Highest target

$500.00

Lowest target

$180.00

Implied upside

43.28%

Target against today's price

largeWhat this means

How far the mean analyst target sits above today's price.

A wide gap, which as often means the price has fallen as that the target is right.

Price against the S&P 500

180 trading days to 2026-08-25

NVDA is 16.7% up over the window, against 11.6% up for the S&P 500 — ahead by 5.1 points.
NVDA +16.7%S&P 500 +11.6%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2025-12-05, so they can be compared directly.
DateCloseNVDA rebasedS&P 500 rebased
2025-12-05$182.19100.0100.0
2025-12-29$187.99103.2100.5
2026-01-21$183.10100.5100.1
2026-02-11$189.82104.2101.0
2026-03-05$183.12100.599.4
2026-03-26$171.0493.994.3
2026-04-17$201.45110.6103.7
2026-05-08$214.95118.0107.7
2026-06-01$224.10123.0110.6
2026-06-23$200.04109.8107.2
2026-07-15$212.50116.6110.2
2026-08-05$219.22120.3112.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health100.023%23.0
Growth & momentum50.022%11.0
Valuation45.018%8.1
Technical70.015%10.5
Risk10.012%1.2
Analyst view100.010%10.0
ESG50.00%0.0
Quality score100%63.8

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

D

63.8 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Shares outstandingValuation24,221,000,000Yahoo Finance
Price to salesValuation20.32Yahoo Finance
Price to bookValuation26.35Yahoo Finance
PEG ratioValuation0.59Yahoo Finance
P/E ratioValuation32.57Yahoo Finance
Forward P/EValuation16.31Yahoo Finance
EV / EBITDAValuation30.24Yahoo Finance
Enterprise valueValuation$5.00TYahoo Finance
Dividend yieldValuation0.48%Yahoo Finance
Stochastic %KTechnical26.2Yahoo Finance
RSI (14)Technical49.2Yahoo Finance
Price vs 50-dayTechnical2.35%Yahoo Finance
Price vs 200-dayTechnical8.92%Yahoo Finance
MACD histogramTechnical-1.29Yahoo Finance
MACDTechnical2.17Yahoo Finance
Bollinger upperTechnical$234.06Yahoo Finance
Bollinger lowerTechnical$195.06Yahoo Finance
Average true rangeTechnical6.40Yahoo Finance
ADXTechnical17.0Yahoo Finance
50-day averageTechnical$207.80Yahoo Finance
200-day averageTechnical$195.26Yahoo Finance
20-day averageTechnical$214.56Yahoo Finance
Volatility, annualisedRisk51.83%Yahoo Finance
Risk categoryRiskVery HighYahoo Finance
Maximum drawdownRisk-66.34%Yahoo Finance
BetaRisk2.21Yahoo Finance
VolumeMarket data80,260,531Yahoo Finance
Previous closeMarket data$208.48Yahoo Finance
OpenMarket data$211.03Yahoo Finance
EmployeesMarket data42,000Yahoo Finance
Day lowMarket data$210.11Yahoo Finance
Day highMarket data$214.73Yahoo Finance
Average volumeMarket data140,101,850Yahoo Finance
52-week lowMarket data$164.07Yahoo Finance
52-week highMarket data$236.54Yahoo Finance
Worst dayGrowth & momentum-16.97%Yahoo Finance
Win rateGrowth & momentum53.11%Yahoo Finance
Sharpe ratioGrowth & momentum1.10Yahoo Finance
Return, year to dateGrowth & momentum12.75%Yahoo Finance
Return, 6 monthsGrowth & momentum8.88%Yahoo Finance
Return, 3 yearsGrowth & momentum353.70%Yahoo Finance
Return, 3 monthsGrowth & momentum0.15%Yahoo Finance
Return, 1 yearGrowth & momentum18.44%Yahoo Finance
Return, 1 monthGrowth & momentum7.95%Yahoo Finance
Best dayGrowth & momentum24.37%Yahoo Finance
Average daily returnGrowth & momentum0.23%Yahoo Finance
Revenue growthFinancial health85.20%Yahoo Finance
RevenueFinancial health$81.61BYahoo Finance
Return on equityFinancial health114.29%Yahoo Finance
Return on assetsFinancial health52.73%Yahoo Finance
Quick ratioFinancial health2.14Yahoo Finance
Profit marginFinancial health62.97%Yahoo Finance
Payout ratioFinancial health0.61%Yahoo Finance
Operating marginFinancial health65.60%Yahoo Finance
Operating cash flowFinancial health$125.65BYahoo Finance
Gross marginFinancial health74.14%Yahoo Finance
Free cash flowFinancial health$46.34BYahoo Finance
Earnings growthFinancial health214.50%Yahoo Finance
Debt to equityFinancial health6.55Yahoo Finance
Current ratioFinancial health3.44Yahoo Finance
Mean price targetAnalyst view$304.73Yahoo Finance
Lowest targetAnalyst view$180.00Yahoo Finance
Implied upsideAnalyst view43.28%Yahoo Finance
Highest targetAnalyst view$500.00Yahoo Finance
ConsensusAnalyst viewStrong BuyYahoo Finance
Analysts coveringAnalyst view59Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more